Awardee OrganizationCOLUMBIA UNIVERSITY HEALTH SCIENCES
Description
Abstract Text
PROTOCOL REVIEW AND MONITORING SYSTEM: PROJECT SUMMARY
The Herbert Irving Comprehensive Cancer Center (HICCC) Protocol Review and Monitoring System (PRMS) is
responsible for independent scientific evaluation, prioritization, and monitoring of all cancer clinical research
studies conducted at Columbia University Irving Medical Center (CUIMC). The PRMS is independent of and
complements the activities of the Institutional Review Boards (IRBs) and HICCC Data Safety and Monitoring
Committee (DSMC). The PRMS encompasses activities of the HICCC Disease Based Teams, Feasibility
Committee, and Protocol Review and Monitoring Committee (PRMC). Although independently managed, these
entities maintain close interactions and collaborations. The Specific Aims of the HICCC PRMS are the following:
(1) Provide scientific review and prioritization of all applicable cancer-related clinical research protocols within
the HICCC, (2) Monitor the progress of ongoing studies to ensure that accrual is sufficient to meet scientific
objectives, (3) Determine whether trials should continue or close for lack of scientific progress, and (4) Assess
and implement the recommendations of the Data Safety and Monitoring Committee (DSMC) regarding issues
that may affect the scientific integrity of interventional trials.
The process for review of cancer clinical research studies through the PRMS are as follows:
Disease Based Teams: Assess new trials for scientific value, fit and prioritization with existing disease-based
research portfolios
Feasibility Committee: Review protocol feasibility to determine that adequate resources are in place prior to
PRMC review
PRMC: Evaluate interventional protocols for scientific merit, innovation, and statistical soundness so as to
assess their priority at initial submission. The PRMC also assess the scientific and accrual progress of
interventional cancer trials at the time of continuing review.
In 2018, the PRMC monitored 381 active interventional studies. The PRMC reviewed 128 new studies (full board
review: 96; expedited review: 32) and 448 amendments.
1
Public Health Relevance Statement
Data not available.
NIH Spending Category
Cancer
Project Terms
AddressAffectAmendmentCancer Center Support GrantCancer InterventionCatchment AreaClinical ResearchClinical Research ProtocolsCollaborationsComplementDataDiseaseEnsureGoalsHerbert Irving Comprehensive Cancer CenterInstitutional Review BoardsInterventionIntervention StudiesIntervention TrialMalignant NeoplasmsMedical centerMonitorProcessProtocols documentationRecommendationResearchResearch PriorityResourcesReview CommitteeSafetyScientific EvaluationSystemTimeUniversitiesVisionWomanage groupbaseexpedited reviewinnovationprogramsresearch studysoundunderserved minority
No Sub Projects information available for 2P30CA013696-45 5616
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 2P30CA013696-45 5616
Patents
No Patents information available for 2P30CA013696-45 5616
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 2P30CA013696-45 5616
Clinical Studies
No Clinical Studies information available for 2P30CA013696-45 5616
News and More
Related News Releases
No news release information available for 2P30CA013696-45 5616
History
No Historical information available for 2P30CA013696-45 5616
Similar Projects
No Similar Projects information available for 2P30CA013696-45 5616